Edwards Lifesciences Corporation (EWL)
XETR
Closed
Aug 24, 2026
Day's Range
75.8452 wk Range
62.00Overview - EWL - Edwards Lifesciences Corporation
Key Statistics
Valuation
Enterprise Value
35.07B
P/E (Trailing)
‪53.48‬
PEG Ratio
‪-2.03‬
Price / Sales (TTM)
‪6.80‬
Price / Book
‪4.83‬
EV / EBITDA
‪20.50‬
Profitability
Gross Margin
‪77.46%‬
Profit Margin
‪15.43%‬
Operating Margin
‪29.83%‬
Return on Assets
‪8.36%‬
Return on Equity
‪9.17%‬
Ownership
Shares Outstanding
576.60M
Float
574.49M
Held by Insiders
‪0.19%‬
Held by Institutions
‪97.11%‬
Price stats
Beta
‪0.84‬
50-Day Avg
‪77.79‬
200-Day Avg
‪72.89‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - EWL - Edwards Lifesciences Corporation
Peers - EWL - Edwards Lifesciences Corporation
Peer Comparison
Compared with companies in Medical Devices listed on XETR.
Profile Summary - EWL - Edwards Lifesciences Corporation
About
Edwards Lifesciences Corporation is a leading global structural heart innovation company focused on advancing treatments for cardiovascular disease. The company specializes in developing and providing innovative medical technologies for structural heart conditions, including transcatheter heart valves that enable…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
